SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
INVA

Innoviva, Inc. (NASDAQ:INVA)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
21.05+0.39 (+1.89%)
 
Market cap
$1.52B
Health Score
Analyst consensus
Listed since
Oct 5, 2004
Website
Insider Score
––Not scored
INVA Insider Score

Insiders here have filed 3 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

Financial Health Score
Strong
From INVA’s reported statements · Q2 2026 (trailing 12 months)
Profitability20 / 20

Keeps a healthy share of every dollar it sells.

Revenue
$443.4M
Net income
$357.2M
Net margin
80.6%
Leverage20 / 20

Little or no net debt.

Total debt
$269.7M
Cash
$570.4M
Net debt / EBITDA
-0.39x
Liquidity20 / 20

Comfortably covers what is due within a year.

Current assets
$753.4M
Current liabilities
$47.1M
Current ratio
16.01
Cash generation20 / 20

The business funds itself from operations.

Operating cash flow
$191.5M
Free cash flow
$188.3M
FCF margin
42.5%
Dilution & runway7 / 20

Heavy dilution — shareholders are paying for the business.

Shares outstanding
73.4M
Share growth (1y)
16.8%

Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.

INVA Income Statement

Fiscal PeriodQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025
Revenue119.59 M97.99 M118.05 M107.80 M100.28 M88.63 M
Revenue Growth (YoY)19.25 %10.56 %28.58 %20.44 %-2.97 %14.37 %
Cost of Revenue28.98 M22.16 M42.43 M25.78 M10.59 M8.84 M
Gross Profit90.62 M75.83 M75.61 M82.02 M89.69 M79.79 M
SG&A Expense34.57 M32.44 M32.07 M27.41 M26.41 M27.49 M
R&D Expense5.19 M5.24 M4.55 M13.67 M7.98 M4.40 M
Operating Expenses39.76 M37.68 M36.62 M47.45 M138.44 M121.22 M
Operating Income50.85 M38.15 M38.99 M34.58 M-48.75 M-41.43 M
Pretax Income-108.02 M234.56 M195.04 M97.82 M72.60 M-38.59 M
Tax Provision-24.60 M47.97 M30.88 M7.91 M8.91 M8.00 M
Net Income-83.42 M186.59 M164.15 M89.91 M63.69 M-46.58 M
EPS (Basic)-1.142.522.191.301.01-0.74
EPS (Diluted)-1.142.221.941.080.77-0.74
Shares Outstanding73.42 M74.16 M74.80 M69.06 M62.87 M62.71 M

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.